Julia Ershova

1.4k total citations
28 papers, 486 citations indexed

About

Julia Ershova is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Julia Ershova has authored 28 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 21 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Julia Ershova's work include Tuberculosis Research and Epidemiology (27 papers), Pneumonia and Respiratory Infections (12 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Julia Ershova is often cited by papers focused on Tuberculosis Research and Epidemiology (27 papers), Pneumonia and Respiratory Infections (12 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Julia Ershova collaborates with scholars based in United States, Switzerland and Russia. Julia Ershova's co-authors include Ekaterina V. Kurbatova, J. Peter Cegielski, Janice Caoili, Peter Cegielski, Ma Tarcela Gler, Tracy Dalton, Grigory Volchenkov, Martie van der Walt, Vaira Leimane and Boris Y. Kazennyy and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Julia Ershova

26 papers receiving 473 citations

Peers

Countries citing papers authored by Julia Ershova

Since Specialization

Citations

This map shows the geographic impact of Julia Ershova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Ershova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Ershova more than expected).

Fields of papers citing papers by Julia Ershova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Ershova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Ershova. The network helps show where Julia Ershova may publish in the future.

Co-authorship network of co-authors of Julia Ershova

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Ershova. A scholar is included among the top collaborators of Julia Ershova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Ershova. Julia Ershova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Implementation of a methodological protocol for the national survey on tuberculosis catastrophic costs in Brazil 2023 ·Revista da Sociedade Brasileira de Medicina Tropical ·Ethel Leonor Nóia Maciel, (unknown), (unknown), Geisa Fregona, (unknown), (unknown), Thiago Nascimento do Prado, Mauro Niskier Sanchez, Fredi Alexander Díaz-Quijano, (unknown), Eliana Zandonade, Inés García Baena, Julia Ershova	2
2	The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021 2023 ·PLoS ONE ·Ethel Leonor Nóia Maciel, (unknown), (unknown), Geisa Fregona, (unknown), Mauro Niskier Sanchez, Adriana da Silva Rezende Moreira, Fredi Alexander Díaz-Quijano, (unknown), Eliana Zandonade, Julia Ershova, Peter Nguhiu, Inés García Baena	3
3	Implementing tuberculosis patient cost surveys in resource-constrained settings: lessons from Tanzania 2022 ·BMC Public Health ·Andrew Martin Kilale, Charles Makasi, (unknown), (unknown), (unknown), (unknown), Omari Kimbute, (unknown), Bhavin Jani, Nyagosya Range, Bernard Ngowi, (unknown), (unknown), (unknown), (unknown), Beatrice Mutayoba, Julia Ershova	0
4	Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households 2022 ·BMC Public Health ·Andrew Martin Kilale, (unknown), Bhavin Jani, Nyagosya Range, Bernard Ngowi, Charles Makasi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Beatrice Mutayoba, (unknown), Julia Ershova	26
5	The economic burden of TB faced by patients and affected families in Papua New Guinea 2022 ·The International Journal of Tuberculosis and Lung Disease ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Julia Ershova	4
6	Pre-treatment loss to follow-up among children with multidrug-resistant tuberculosis in South Africa, 2008–2010 2020 ·PLoS ONE ·(unknown), Linda Erasmus, Julia Ershova, Sarah E. Smith, Norbert Ndjeka, Laura Jean Podewils	4
7	Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia 2020 ·BMC Infectious Diseases ·Julia Ershova, Grigory Volchenkov, (unknown), (unknown), (unknown), (unknown), Olga V. Demikhova, Л. Н. Черноусова, I. А. Vаsilyevа, (unknown), J. Peter Cegielski, Ekaterina V. Kurbatova	8
8	Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion 2020 ·The Journal of Infectious Diseases ·Eleanor S. Click, Ekaterina V. Kurbatova, Heather Alexander, Tracy Dalton, Michael P. Chen, James E. Posey, Julia Ershova, J. Peter Cegielski	14
9	Comparison of Sputum-Culture Conversion forMycobacterium bovisandM. tuberculosis 2017 ·Emerging infectious diseases ·(unknown), Joseph S. Cavanaugh, Benjamin J. Silk, Julia Ershova, Gerald H. Mazurek, Philip LoBue, Patrick K. Moonan	7
10	The Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based Survey 2016 ·PLoS ONE ·(unknown), (unknown), Evelyn Lavu, (unknown), (unknown), Chris Coulter, Julia Ershova, Olga Tosas, Matteo Zignol, (unknown), Tauhid Islam	38
11	Epidemiology of drug-resistant tuberculosis among children and adolescents in South Africa, 2005–2010 2015 ·The International Journal of Tuberculosis and Lung Disease ·(unknown), (unknown), Martie van der Walt, Sarah E. Smith, (unknown), (unknown), Sapna Bamrah Morris, Norbert Ndjeka, Julia Ershova, Nazir Ismail, Deron C. Burton, Heather Menzies	17
12	Antituberculosis Drug Resistance Survey in Lesotho, 2008-2009: Lessons Learned 2015 ·PLoS ONE ·(unknown), (unknown), Julia Ershova, (unknown), (unknown), (unknown), (unknown), Laura K. Beres, (unknown), Timothy H. Holtz	6
13	Evaluation of community‐based treatment for drug‐resistant tuberculosis in Bangladesh 2015 ·Tropical Medicine & International Health ·Joseph S. Cavanaugh, Ekaterina V. Kurbatova, Negar Niki Alami, Joan M. Mangan, (unknown), Shahriar Ahmed, (unknown), (unknown), Paul Daru, Julia Ershova, (unknown), Sayera Banu, James D. Heffelfinger	2
14	Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia 2015 ·Emerging infectious diseases ·Julia Ershova, Grigory Volchenkov, (unknown), (unknown), (unknown), (unknown), J. Peter Cegielski, Ekaterina V. Kurbatova	9
15	Evaluation of adherence to national treatment guidelines among tuberculosis patients in three provinces of South Africa 2014 ·South African Medical Journal ·Julia Ershova, Laura Jean Podewils, Liza Bronner Murrison, Heather Stockwell, Sicelo S. Dlamini, L D Mametja	16
16	Mortality Among Tuberculosis Patients With Acquired Resistance to Second-line Antituberculosis Drugs--United States, 1993-2008 2014 ·Clinical Infectious Diseases ·Julia Ershova, Ekaterina V. Kurbatova, Patrick K. Moonan, J. Peter Cegielski	5
17	Weight Gain and Response to Treatment for Multidrug-Resistant Tuberculosis 2013 ·American Journal of Tropical Medicine and Hygiene ·Ma Tarcela Gler, (unknown), Janice Caoili, Julia Ershova, Peter Cegielski, John L. Johnson	35
18	Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study 2012 ·The Lancet ·Tracy Dalton, Peter Cegielski, Somsak Akksilp, Luis Asencios, Janice Caoili, Sang-Nae Cho, В В Ерохин, Julia Ershova, Ma Tarcela Gler, Boris Y. Kazennyy, Hee Jin Kim, Kai Kliiman, Ekaterina V. Kurbatova, Charlotte Kvasnovsky, Vaira Leimane, Martie van der Walt, Laura E. Via, Grigory Volchenkov, (unknown), Hyungseok Kang	163
19	Acquired Resistance to Second-Line Drugs Among Persons With Tuberculosis in the United States 2012 ·Clinical Infectious Diseases ·Julia Ershova, Ekaterina V. Kurbatova, Patrick K. Moonan, J. Peter Cegielski	20
20	Performance of Cepheid® Xpert MTB/RIF® and TB-Biochip® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis 2012 ·European Journal of Clinical Microbiology & Infectious Diseases ·Ekaterina V. Kurbatova, Denise A. Kaminski, В В Ерохин, Grigory Volchenkov, (unknown), Л. Н. Черноусова, Olga V. Demikhova, Julia Ershova, (unknown), Т. А. Кузнецова, Е. Е. Ларионова, Т. Г. Смирнова, (unknown), (unknown), (unknown), (unknown), J. Peter Cegielski	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact